Indoco Remedies Q1 PAT may dip 0.1% YoY to Rs 38.5 cr: Nirmal Bang
Net Sales are expected to increase by 6.8 percent Y-o-Y (up 1.8 percent Q-o-Q) to Rs 435.9 crore, according to Nirmal Bang.12-07-2023
12-07-2023
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
DISCLOSURE UNDER REGULATION 30 OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015-COMPLETION OF INSPECTION AT INDOCO REMEDIES GOA PLANT -III11-07-2023
INDOCO REMEDIES LTD. - 532612 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate issued by our Registrar & Transfer Agent of the Company, confirming compliance under Reg 74(5) of SEBI (D&P) Reg.2018 for the quarter ended 30-06-202307-07-2023
INDOCO REMEDIES LTD. - 532612 - Closure of Trading Window
This is to inform you that Trading Window for trading/dealing in Equity Shares of the Company will remain closed from 01st July , 2023 until 48 hours after declaration of standalone and consolidated financial results of the Company for the quarter ending 30th June, 2023.29-06-2023
INDOCO REMEDIES LTD. - 532612 - Disclosure Of Voting Results Of Postal Ballot Pursuant To Regulation 44 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 Along With Scrutinizers Report
In terms of the Regulation 44 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed herewith, the Voting Results on the special business transacted through Postal Ballot Notice dated May 23, 2023 along with the Scrutinizer''s Report dated June 26, 202327-06-2023
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of Analyst/ Institutional Investor/Investors Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201523-06-2023
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Notice for transfer of equity shares of the Company to the Investor Education and Protection Fund ('IEPF')20-06-2023
INDOCO REMEDIES LTD. - 532612 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditi M Panandikar & Others13-06-2023
INDOCO REMEDIES LTD. - 532612 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Madhura Ramani & PACS12-06-2023